INTRODUCTION: To expand the donor pool, kidney transplants are being performed using donors who were previously considered unacceptable. We applied the United Network for Organ Sharing criteria to define expanded criteria donors (ECD) within the donation after cardiac death (DCD) and donation after brain stem death (DBD) cohorts. We compared outcomes of DCD and DBD transplants with and without (standard criteria donor [SCD]) the ECD criteria. METHODS: This was a single-center retrospective study of all deceased donor transplants from 2004 to 2010 (n=359). Four groups were identified--DBD-SCD (n=154), DBD-ECD (n=93), DCD-SCD (n=78), and DCD-ECD (n=34). Kaplan-Meier analysis of graft and patient survival and multiple regression analysis of 1-year graft function were performed. RESULTS: One-year and two-year uncensored graft survivals were similar between DCD-ECD and DCD-SCD cohorts (1 year, 90% and 93%; 2 years, 81% and 93% respectively; log-rank test P=0.2). Median estimated glomerular filtration rate (eGFR) was lower in DCD-ECD recipients at 12 months (41 vs. 53 mL/min, P=0.003) and 24 months (33 vs. 54 mL/min, P<0.001) compared with DCD-SCD recipients. Compared with DBD-ECD recipients also at 24 months, DCD-ECD recipients showed a lower graft function (median, eGFR 33 vs. 47 mL/min; P=0.007) but similar graft survival. Expanded criteria donor status (B=-9.7, P=0.01) was associated with a lower 1-year eGFR within the DCD cohort, with donor age (B=-0.42, P=0.002) being the only significant ECD variable. CONCLUSION: Short-term graft survival in DCD-ECD transplants was comparable to DCD-SCD and DBD-ECD transplants albeit with poorer allograft function at 2 years. Quality-of-life studies are needed to determine the true value of these transplants, particularly when performed to older recipients.
INTRODUCTION: To expand the donor pool, kidney transplants are being performed using donors who were previously considered unacceptable. We applied the United Network for Organ Sharing criteria to define expanded criteria donors (ECD) within the donation after cardiac death (DCD) and donation after brain stem death (DBD) cohorts. We compared outcomes of DCD and DBD transplants with and without (standard criteria donor [SCD]) the ECD criteria. METHODS: This was a single-center retrospective study of all deceased donor transplants from 2004 to 2010 (n=359). Four groups were identified--DBD-SCD (n=154), DBD-ECD (n=93), DCD-SCD (n=78), and DCD-ECD (n=34). Kaplan-Meier analysis of graft and patient survival and multiple regression analysis of 1-year graft function were performed. RESULTS: One-year and two-year uncensored graft survivals were similar between DCD-ECD and DCD-SCD cohorts (1 year, 90% and 93%; 2 years, 81% and 93% respectively; log-rank test P=0.2). Median estimated glomerular filtration rate (eGFR) was lower in DCD-ECD recipients at 12 months (41 vs. 53 mL/min, P=0.003) and 24 months (33 vs. 54 mL/min, P<0.001) compared with DCD-SCD recipients. Compared with DBD-ECD recipients also at 24 months, DCD-ECD recipients showed a lower graft function (median, eGFR 33 vs. 47 mL/min; P=0.007) but similar graft survival. Expanded criteria donor status (B=-9.7, P=0.01) was associated with a lower 1-year eGFR within the DCD cohort, with donor age (B=-0.42, P=0.002) being the only significant ECD variable. CONCLUSION: Short-term graft survival in DCD-ECD transplants was comparable to DCD-SCD and DBD-ECD transplants albeit with poorer allograft function at 2 years. Quality-of-life studies are needed to determine the true value of these transplants, particularly when performed to older recipients.
Authors: Christopher J Zimmermann; Nathan D Baggett; Lauren J Taylor; Anne Buffington; Joseph Scalea; Norman Fost; Kenneth D Croes; Joshua D Mezrich; Margaret L Schwarze Journal: Am J Transplant Date: 2019-03-14 Impact factor: 8.086
Authors: Dagmara McGuinness; Suhaib Mohammed; Laura Monaghan; Paul A Wilson; David B Kingsmore; Oliver Shapter; Karen S Stevenson; Shana M Coley; Luke Devey; Robert B Kirkpatrick; Paul G Shiels Journal: Aging Cell Date: 2018-08-09 Impact factor: 9.304
Authors: Jesus M Sierra Parraga; Kaithlyn Rozenberg; Marco Eijken; Henri G Leuvenink; James Hunter; Ana Merino; Cyril Moers; Bjarne K Møller; Rutger J Ploeg; Carla C Baan; Bente Jespersen; Martin J Hoogduijn Journal: Front Immunol Date: 2019-04-10 Impact factor: 7.561
Authors: María José Pérez-Sáez; Omar Lafuente Covarrubias; Domingo Hernández; Francesc Moreso; Edoardo Melilli; Javier Juega; Erika de Sousa; Paula López-Sánchez; María Luisa Rodríguez-Ferrero; Naroa Maruri-Kareaga; María Dolores Navarro; Rosalía Valero; María Auxiliadora Mazuecos; Francisco Llamas; Paloma Martín-Moreno; Antón Fernández-García; Jordi Espí; Carlos Jiménez; Ana Ramos; Eva Gavela; Julio Pascual; Jose M Portolés Journal: BMC Nephrol Date: 2019-06-26 Impact factor: 2.388
Authors: Anna Buxeda; Gonzalo Velis; Carlos Arias-Cabrales; Ana Zapatero; Carla Burballa; Dolores Redondo-Pachón; Marisa Mir; Marta Crespo; Julio Pascual; María José Pérez-Sáez Journal: Clin Kidney J Date: 2020-09-10
Authors: Sile Yu; Jane J Long; Yifan Yu; Mary G Bowring; Jennifer D Motter; Tanveen Ishaque; Niraj Desai; Dorry L Segev; Jacqueline M Garonzik-Wang; Allan B Massie Journal: Am J Transplant Date: 2020-09-17 Impact factor: 8.086